55.41
price up icon3.17%   1.70
pre-market  Vorhandelsmarkt:  54.81   -0.60   -1.08%
loading
Schlusskurs vom Vortag:
$53.71
Offen:
$53.19
24-Stunden-Volumen:
7.54M
Relative Volume:
1.51
Marktkapitalisierung:
$9.86B
Einnahmen:
$803.32M
Nettoeinkommen (Verlust:
$-709.10M
KGV:
-7.1036
EPS:
-7.8003
Netto-Cashflow:
$-212.68M
1W Leistung:
-7.59%
1M Leistung:
-18.07%
6M Leistung:
-27.38%
1J Leistung:
-11.00%
1-Tages-Spanne:
Value
$51.69
$55.46
1-Wochen-Bereich:
Value
$51.69
$62.00
52-Wochen-Spanne:
Value
$36.22
$104.32

Tempus Ai Inc Stock (TEM) Company Profile

Name
Firmenname
Tempus Ai Inc
Name
Telefon
800-976-5448
Name
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Name
Mitarbeiter
2,400
Name
Twitter
Name
Nächster Verdiensttermin
2026-02-24
Name
Neueste SEC-Einreichungen
Name
TEM's Discussions on Twitter

Compare TEM vs VEEV, BTSG, HQY, WAY

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
TEM
Tempus Ai Inc
55.41 9.56B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
VEEV
Veeva Systems Inc
182.86 29.01B 3.08B 860.33M 1.35B 5.1463
Health Information Services icon
BTSG
Brightspring Health Services Inc
40.13 7.36B 11.99B 24.18M 234.31M 0.2956
Health Information Services icon
HQY
Healthequity Inc
77.39 6.46B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
26.02 4.68B 906.14M -52.62M 89.62M -0.3621

Tempus Ai Inc Stock (TEM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-02-19 Eingeleitet Mizuho Outperform
2026-02-17 Eingeleitet Robert W. Baird Outperform
2025-12-02 Fortgesetzt Morgan Stanley Overweight
2025-10-21 Herabstufung TD Cowen Buy → Hold
2025-10-20 Eingeleitet Canaccord Genuity Buy
2025-09-02 Eingeleitet H.C. Wainwright Buy
2025-04-21 Eingeleitet BTIG Research Buy
2025-02-25 Herabstufung JP Morgan Overweight → Neutral
2025-02-12 Herabstufung William Blair Outperform → Mkt Perform
2025-02-05 Fortgesetzt TD Cowen Buy
2024-12-13 Eingeleitet Wolfe Research Outperform
2024-12-09 Eingeleitet Guggenheim Buy
2024-11-11 Herabstufung Stifel Buy → Hold
2024-10-02 Herabstufung BofA Securities Buy → Neutral
2024-08-12 Eingeleitet Piper Sandler Neutral
2024-07-09 Eingeleitet BofA Securities Buy
2024-07-09 Eingeleitet JP Morgan Overweight
2024-07-09 Eingeleitet Longbow Buy
2024-07-09 Eingeleitet Loop Capital Buy
2024-07-09 Eingeleitet Morgan Stanley Overweight
2024-07-09 Eingeleitet Needham Buy
2024-07-09 Eingeleitet Stifel Buy
2024-07-09 Eingeleitet TD Cowen Buy
2024-07-09 Eingeleitet William Blair Outperform
Alle ansehen

Tempus Ai Inc Aktie (TEM) Neueste Nachrichten

pulisher
Feb 25, 2026

Cathie Wood Is Buying The Tempus AI Dip, Ark Snaps Up Stock Worth $11 Million - Benzinga

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI (TEM) Loss Deepens To US$0.30 EPS As Premium Valuation Thesis Faces Test - simplywall.st

Feb 25, 2026
pulisher
Feb 25, 2026

Cathie Wood’s ARK sells PagerDuty stock, buys Tempus AI - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI sold off after a beat but the rebound case is building - MSN

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI Sold Off After a Beat—But the Rebound Case Is Building - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI: No AI Interruption Detected (NASDAQ:TEM) - Seeking Alpha

Feb 25, 2026
pulisher
Feb 25, 2026

Promising Artificial Intelligence Stocks To Follow NowFebruary 25th - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI (TEM) Stock: Insider Selling Tops $37M as JPMorgan Cuts Price Target - CoinCentral

Feb 25, 2026
pulisher
Feb 25, 2026

JPMorgan Chase & Co. Issues Pessimistic Forecast for Tempus AI (NASDAQ:TEM) Stock Price - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI (NASDAQ:TEM) Price Target Cut to $75.00 by Analysts at Needham & Company LLC - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI (NASDAQ:TEM) Trading Down 7.4% After Analyst Downgrade - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Stifel cuts Tempus AI stock price target to $60 on valuation - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI Posts 83% Revenue Growth Yet Stumbles on Full Year Profitability Target - 24/7 Wall St.

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI: Accelerating AI-Driven Precision Medicine Growth with Undervalued Long-Term Potential - TipRanks

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI (NASDAQ:TEM) Price Target Lowered to $90.00 at BTIG Research - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Expert Outlook: Tempus AI Through The Eyes Of 6 Analysts - Benzinga

Feb 25, 2026
pulisher
Feb 25, 2026

TEM Q4 Earnings Miss, Revenues Beat, Stock Down in After-Market - Zacks Investment Research

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI (TEM) stock drops 4% in premarket as 2026 outlook lands after Q4 results - TechStock²

Feb 25, 2026
pulisher
Feb 25, 2026

Billionaire David Tepper Goes Big on Micron, Meta, and Alphabet in AI All-In - AOL.com

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI Q4 Earnings Call Highlights - MarketBeat

Feb 25, 2026
pulisher
Feb 24, 2026

Tempus AI Inc Q4 Loss Increases, But Beats Estimates - Nasdaq

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI reports Q4 EPS (4c), consensus (5c) - TipRanks

Feb 24, 2026
pulisher
Feb 24, 2026

AMD, Zeta Global, MercadoLibre, Tempus AI And Workday: Why These 5 Stocks Are On Investors' Radars Today - Benzinga

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI stock drops despite Q4 earnings beat: Details - MSN

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI (TEM) Reports Q4 Loss, Beats Revenue Estimates - Nasdaq

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI Beats Q4 Earnings Expectations but Shares Decline Afterhours - MLQ.ai

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI Inc (NASDAQ:TEM) Reports Strong Q4 Revenue Beat and First Positive Adjusted EBITDA - ChartMill

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI falls despite Q4 beats, 2026 revenue guidance above consensus - MSN

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI Stock Drops Despite Q4 Earnings Beat: Details - Benzinga

Feb 24, 2026
pulisher
Feb 24, 2026

Why Tempus AI Stock Is Dropping Despite Bold Outlook - TipRanks

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI Reports Strong Q4 Growth and Positive EBITDA - TipRanks

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI falls despite guidance beat on muted outlook By Investing.com - Investing.com Canada

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI falls despite guidance beat on muted outlook - Investing.com

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI (NASDAQ:TEM) Releases Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI Q4 Non-GAAP Loss Narrows, Revenue Rises; 2026 Revenue Outlook Set - marketscreener.com

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus: Q4 Earnings Snapshot - marketscreener.com

Feb 24, 2026
pulisher
Feb 24, 2026

(TEM) Tempus AI Expects 2026 Revenue of About $1.59B, vs. FactSet Est of $1.58B - marketscreener.com

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI slides after missing Q4 EBITDA target - Sherwood News

Feb 24, 2026
pulisher
Feb 24, 2026

Earnings Summary: Tempus AI Q4 - Benzinga

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus Reports Fourth Quarter and Full Year 2025 Results - Business Wire

Feb 24, 2026
pulisher
Feb 24, 2026

Live Earnings: Will Tempus AI Surprise Wall Street Tonight? - 24/7 Wall St.

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI Stock Underperforming Into Earnings – What To Expect After The Bell - AskTraders.com

Feb 24, 2026
pulisher
Feb 24, 2026

Artificial Intelligence Stocks To Add to Your WatchlistFebruary 24th - MarketBeat

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI faces earnings test as losses expected to widen By Investing.com - Investing.com Canada

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI faces earnings test as losses expected to widen - Investing.com

Feb 24, 2026
pulisher
Feb 24, 2026

Navigating the Next Phase: Tempus AI's Strategic Position in Healthcare AI - AD HOC NEWS

Feb 24, 2026
pulisher
Feb 24, 2026

Krane Funds Advisors LLC Raises Stake in Tempus AI, Inc. $TEM - MarketBeat

Feb 24, 2026
pulisher
Feb 24, 2026

A Look At Tempus AI’s Valuation As Mixed Recent Returns Raise Questions - simplywall.st

Feb 24, 2026
pulisher
Feb 24, 2026

Tempus AI builds on FDA win with Median partnership for lung cancer detection - Mugglehead Investment Magazine

Feb 24, 2026
pulisher
Feb 23, 2026

Tempus AI, Inc. (TEM) Stock Analysis: Uncovering a 48.56% Potential Upside in Healthcare Tech - DirectorsTalk Interviews

Feb 23, 2026
pulisher
Feb 23, 2026

Why Applovin Stock Popped Today - AOL.com

Feb 23, 2026

Finanzdaten der Tempus Ai Inc-Aktie (TEM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Tempus Ai Inc-Aktie (TEM) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
LEFKOFSKY ERIC P
CEO and Chairman
Feb 19 '26
Sale
59.05
13,587
802,312
1,989,626
Phelps Erik
EVP, Chief Admin. Officer
Feb 19 '26
Sale
59.43
9,464
562,472
79,816
Bartolucci Ryan M
Chief Accounting Officer
Feb 19 '26
Sale
59.05
2,902
171,363
41,159
Polovin Andrew
EVP, Chief Legal Officer
Feb 20 '26
Sale
60.31
10,949
660,292
126,918
Polovin Andrew
EVP, Chief Legal Officer
Feb 19 '26
Sale
59.05
8,143
480,844
99,447
Fukushima Ryan
Chief Executive Officer, Data
Feb 19 '26
Sale
59.05
9,592
566,408
694,354
Rogers James William
Chief Financial Officer
Feb 19 '26
Sale
59.05
10,084
595,460
101,166
$40.13
price down icon 1.64%
health_information_services HQY
$77.39
price up icon 2.42%
health_information_services WAY
$26.02
price up icon 6.64%
$25.10
price up icon 2.87%
$43.67
price up icon 7.43%
Kapitalisierung:     |  Volumen (24h):